SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Office worker man feeling depressed and tired from overwork and pressure at workplace. Flat design vector illustration with red background
C-suite
With Political Disarray at an All-Time High, the Pharma CEO Chair Is a Lonely Gig
As the political winds shift on a whim and public distrust of the pharma industry reaches fever pitch over drug pricing, executives are being asked to navigate an impassible path.
August 27, 2025
 · 
7 min read
 · 
Annalee Armstrong
AI ethics, Legal technology and digital justice concept with glowing polygonal balance scale connected to circuit board on dark blue background. Futuristic low poly style, abstract vector illustration
Artificial Intelligence
Generate’s Chief IP ‘Geek’ Wants To Answer AI’s Biggest Legal Questions
Generate:Biomedicines’ Nicole Clouse is one of the key legal minds trying to understand who owns what AI creates. The answers are critical to the future of biotech.
August 27, 2025
 · 
5 min read
 · 
Annalee Armstrong
a 3D rendering of a capsule-shaped pill showcases the flag of United State of America and flag of China
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
If the trend holds, IQVIA expects 2025 deal volume between Chinese and multinational companies to easily eclipse the 100 agreements signed in 2024.
August 27, 2025
 · 
2 min read
 · 
Annalee Armstrong
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VII
Obesity
Lilly Plots Path to FDA After Second Phase III Readout for Orforglipron
While Truist Securities analysts said the results from the ATTAIN-2 trial leave “room for competition,” they also pointed to a manufacturing advantage that could unlock a “double-digit billion dollar opportunity” for Eli Lilly.
August 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: CDC signage at its headquarters in Georg
COVID-19
CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup
The MIT professor of management, who already sits on the CDC’s revamped immunization advisory committee, is a known skeptic of vaccines, particularly mRNA technology.
August 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative picture image collage banner of guy worker jump from financial charts determined company success.
Rare diseases
Argenx Eyes ‘Broadest Label’ for Vyvgart in Myasthenia Gravis After Positive Phase III Data
Based on new data, argenx expects to file for the expansion of Vyvgart’s label into patients with generalized myasthenia gravis who are negative for antibodies against the AChR marker—an indication William Blair analysts called the broadest option in this disease space.
August 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Close-Up Of Syringe With Bottles Against Blue Background
Vaccines
Trump, Kennedy Could Ban COVID-19 Vaccine ‘Within Months’: Report
The White House has denied reports that the government could soon ban COVID-19 vaccines, noting that in the absence of an official announcement, “any discussion about HHS policy should be dismissed as baseless speculation.”
August 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Concept art for large layoffs showing a line of blocks a cliff
Layoffs
Appia, Former Kite Cell Therapy Collaborator, Shuts Down
Appia Bio’s shutdown continues an unfortunate trend this year that has seen biotech closures nearly every month.
August 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Oral Weight-Loss Race Heats Up as New Data From Lilly, Viking Reset Expectations
Closely watched data from Eli Lilly and Viking Therapeutics this month have reignited the discussion around oral weight-loss drugs—and their ultimate place within the anti-obesity medication market.
August 26, 2025
 · 
1 min read
 · 
Jef Akst
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS